Lotiglipron
Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus
Pfizer · Phase 1 · Completed · Enrollment 34
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| PF-07081532 | T2D only | n/r | n/r | n/r | n/r |
| Placebo | T2D only | n/r | n/r | n/r | n/r |